Atropine is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Mwi. The primary component is Atropine Sulfate.
Product ID | 13985-606_7d53942b-38a5-4316-9180-2fad2eb727db |
NDC | 13985-606 |
Product Type | Human Prescription Drug |
Proprietary Name | Atropine |
Generic Name | Atropine Sulfate |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2015-03-23 |
Marketing Category | NDA / NDA |
Application Number | NDA206289 |
Labeler Name | MWI |
Substance Name | ATROPINE SULFATE |
Active Ingredient Strength | 10 mg/mL |
Pharm Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-03-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206289 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-03-23 |
Ingredient | Strength |
---|---|
ATROPINE SULFATE | 10 mg/mL |
SPL SET ID: | 590a4e7b-565f-415f-a8e4-499a382c9a3b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
13985-606 | Atropine | Atropine |
17478-215 | Atropine | Atropine |
50090-3104 | Atropine | Atropine |
0065-0817 | atropine sulfate | atropine sulfate |
0404-9819 | ATROPINE SULFATE | atropine sulfate |
0404-9820 | Atropine Sulfate | Atropine Sulfate |
0404-9821 | Atropine Sulfate | Atropine Sulfate |
0404-9822 | Atropine Sulfate | Atropine Sulfate |
0404-9823 | Atropine Sulfate | Atropine Sulfate |
0404-9824 | Atropine Sulfate | Atropine Sulfate |
0409-1630 | Atropine Sulfate | ATROPINE SULFATE |
0409-4910 | ATROPINE SULFATE | ATROPINE SULFATE |
0409-4911 | ATROPINE SULFATE | ATROPINE SULFATE |
0409-9630 | Atropine Sulfate | ATROPINE SULFATE |
0065-0303 | Isopto Atropine | atropine sulfate |